The New York Sun

Join
Opinion

In Libertarian Land, the Abortion Pill Question Would Be Left to the States

It is they who would have to dodge — or not — the unintended consequences of banning mifepristone.

AP/Allen G. Breed, file
The drug mifepristone at the West Alabama Women's Center at Tuscaloosa, in March 2022. AP/Allen G. Breed, file
JEFFREY MIRON
JEFFREY MIRON

In the wake of the Supreme Court’s Dobbs decision, which reversed  Roe v. Wade’s guarantee of a right to abortion, government policy toward mifepristone, the “abortion pill,” has become a focal point for debates about abortion policy.

Have an account? Log In

To continue reading, please select:

Limited Access

Enter your email to read for FREE

Get 1 FREE article

Continue with
or
Unlimited Access

Join the Sun for a PENNY A DAY

$0.01/day for 60 days

Cancel anytime

100% ad free experience

Unlimited article and commenting access

Full annual dues ($120) billed after 60 days

View all membership options
By continuing you agree to our
Privacy Policy and Terms of Service.
JEFFREY MIRON
JEFFREY MIRON

Mr. Miron is vice president for research at the Cato Institute and director of graduate and undergraduate studies in the Department of Economics at Harvard University.

Advertisement
The New York Sun

Sections

NationalForeignPoliticsArts+EconomyEducationJusticeOpinionWatchCrossword

More

MembershipBecome a FounderAdvertiseEventsNewslettersShopSubmissionsContactLegalAbout

© 2025 The New York Sun Company, LLC. All rights reserved.

Use of this site constitutes acceptance of our Terms of Use and Privacy Policy. The material on this site is protected by copyright law and may not be reproduced, distributed, transmitted, cached or otherwise used.

The New York Sun

Sign in or  Create a free account

or
By continuing you agree to our Privacy Policy and Terms of Use